Johannes R Lemke

42PUBLICATIONS

330CO-AUTHORS

NeurogeneticsCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Agricultural molecular engineering of nucleic acids and proteinsEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (42)

Sort by Publication Date:

|Jul 02, 2026

Clinical impact of genetic testing in inherited kidney diseases.

|Jun 05, 2026

PRS-BC<sub>313</sub> integration for tailored breast cancer prevention in female patients and their healthy relatives.

|Jan 28, 2026

Predictive value of seizure onset for gross motor dysfunction in individuals with pathogenic GABRB2 and GABRB3 variants.

Sebastian Ortiz, Leonardo Affronte, Chiara Bagliani

|Jan 07, 2026

Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.

Johannes R Lemke, Andrea Eoli, Ilona Krey

|Jan 05, 2026

Memantine treatment in individuals with GRIN gain-of-function variants is associated with improvements in behavior, development, and seizure frequency.

Maike Karnstedt, Riley E Perszyk, Scott J Myers

|Oct 14, 2025

GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.

Johannes R Lemke, Andrea Eoli, Ilona Krey

Pageof 7

Frequent Collaborators

11 joint publications

Rami Jamra

10 joint publications

Konrad Platzer

Rikke S Møller

Steffen Syrbe

Patrick May

Stephen F Traynelis

Diana Le Duc

Ingo Borggraefe

Sarah Weckhuysen

Eduardo Pérez-Palma

Frequent Collaborators

11 joint publications

Rami Jamra

10 joint publications

Konrad Platzer

7 joint publications

Rikke S Møller

6 joint publications

Steffen Syrbe